TP53 Genetic Polymorphisms and Environmental Risk Factors Associated with Cervical Carcinogenesis in A Cohort of Brazilian Women with Cervical Lesions

REFERENCES

• Agorastos , T. , Lambropoulos , A. F. , Constantinidis , T. C. , Kotsis , A. and Bontis , J. N. 2000 . p53 codon 72 polymorphism and risk of intra-epithelial and invasive cervical neoplasia in Greek women . Eur. J .Cancer Prev. , 9 : 113 – 118 .
   PubMedGoogle Scholar
• Andersson , S. , Rylander , E. , Strand , A. , Sällström , J. and Wilander , E. 2001 . The significance of p53 codon 72 polymorphism for the development of cervical adenocarcinomas . Br. J. Cancer , 85 : 1153 – 1156 .
   PubMedGoogle Scholar
• Arends , M. J. , Buckley , C. H. and Wells , M. G. 1998 . Aetiology, pathogenesis, and pathology of cervical neoplasia . J. Clin. Pathol. , 51 : 96 – 103 .
   PubMed Web of Science ®Google Scholar
• Auborn , K. J. , Woodworth , C. , DiPaolo , J. A. and Bradlow , H. L. 1991 . The interaction between HPV infection and estrogen metabolism in cervical carcinogenesis . Int. J. Cancer , 49 : 867 – 869 .
   PubMed Web of Science ®Google Scholar
• Baek , W. K. , Cho , J. W. , Suh , S. I. , Suh , M. H. , Shin , D. H. , Cho , C. H. , Lee , T. S. and Cha , S. D. 2000 . p53 codon 72 polymorphism and risk of cervical carcinoma in Korean women . J. Korean Med. Sci. , 15 : 65 – 67 .
   PubMedGoogle Scholar
• Beckman , G. , Birgander , R. , Sjalander , A. , Saha , N. , Holmberg , P. A. , Kivelä , A. and Beckman , L. 1994 . Is p53 polymorphism maintained by natural selection? . Hum. Hered. , 44 : 266 – 270 .
   PubMed Web of Science ®Google Scholar
• Brasil, INCA . 2004 . Inquérito domiciliar sobre comportamentos de risco e morbidade referida de doenças e agravos não transmissíveis: Brasil, 15 capitais e Distrito Federal, 2002–2003 , 186 Rio de Janeiro : INCA .
   Google Scholar
• Cenci , M. , French , D. , Pisani , T. , Alderisio , M. , Lombardi , A. M. , Marchese , R. , Colelli , F. and Vecchione , A. 2003 . p53 polymorphism at codon 72 is not a risk factor for cervical carcinogenesis in central Italy . Anticancer Res. , 23 : 1385 – 1387 .
   PubMedGoogle Scholar
• Cho , N. H. , Lim , S. Y. , Kim , Y. T. , Kim , D. , Kim , Y. S. and Kim , J. W. 2003 . G2 checkpoint in uterine cervical cancer with HPV 16 E6 according to p53 polymorphism and its screening value . Gynecol. Oncol. , 90 : 15 – 22 .
   PubMedGoogle Scholar
• Crook , T. , Storey , A. , Almond , N. , Osborn , K. and Crawford , L. 1988 . Human papillomavirus type 16 cooperates with activated ras and fos oncogenes in the hormone-dependent transformation of primary mouse cells . Proc. Natl. Acad. Sci. USA , 85 : 8820 – 8824 .
   PubMed Web of Science ®Google Scholar
• Damin , A. P. , Frazzon , A. P. , Roehe , A. , Hermes , V. , Zehler , C. and Alexandre , C. O. 2006 . Evidence for an association of TP53 codonm 72 polymorphism with breast cancer risk . Cancer Detect. Prev. , 30 : 523 – 529 .
   PubMedGoogle Scholar
• Drummond , S. N. , De Marco , L. , Pordeus Ide , A. , Barbosa , A. A. and Gomez , R. S. 2002 . Tp53 codon 72 polymorphism in oral squamous cell carcinoma . Anticancer Res. , 22 : 3379 – 381 .
   PubMed Web of Science ®Google Scholar
• Fernandes , T. A. , Lima , G. L. , de Souza , F. C. , Fernandes , J. V. and Meissner , R. V. 2008 . Evaluation of the polymorphism in the exon 2 to 4 of the TP53 in cervical carcinoma patients from a Brazilian population . Cell Mol. (Noisy-le-grand) , 54 ( suppl. ) : 1025 – 1031 .
   Google Scholar
• Gao , W. M. , Mady , H. H. , Yu , G. Y. , Siegfried , J. M. , Luketich , J. D. , Melhem , M. F. and Keohavong , P. 2003 . Comparison of p53 mutations between adenocarcinoma and squamous cell carcinoma of the lung: Unique spectra involving G to A transitions and G to T transversions in both histologic types . Lung Cancer , 40 : 141 – 150 .
   PubMed Web of Science ®Google Scholar
• Govan , V. A. , Loubser , S. , Saleh , D. , Hoffman , M. and Williamson , A. L. 2007 . No relationship observed between human p53 codon-72 genotype and HPV-associated cervical cancer in a population group with a low arginine-72 allele frequency . Int. J. Immunogenet. , 34 : 213 – 217 .
   PubMedGoogle Scholar
• Hellberg , D. , Nilsson , S. , Haley , N. J. , Hoffman , D. and Wynder , E. 1988 . Smoking and cervical intraepithelial neoplasia: Nicotine and cotinine in serum and cervical mucus in smokers and nonsmokers . Am. J. Obstet. Gynecol. , 158 : 910 – 913 .
   PubMed Web of Science ®Google Scholar
• Humbey , O. , Aubin , F. , Cairey-Remonnay , S. , Riethmuller , D. , Pretet , J. L. , Fest , T. , Seilles , E. and Mougin , C. 2002 . TP53 polymorphism at exon 4 in Caucasian women from eastern France: Lack of correlation with HPV status and grade of cervical precancerous lesions . Eur. J. Obstet. Gynecol. Reprod. Biol. , 103 : 60 – 64 .
   PubMedGoogle Scholar
• Hussain , S. P. and Harris , C. C. 1998 . “ Molecular epidemiology of human cancer ” . In Recent results in cancer research , 22 – 36 . Berlin : Springer-Verlag .
   Google Scholar
• IARC. 1986. Tobacco smoking. IARC Monogr. Eval. Carcinogen. Risks Hum. http://monographs.iarc.fr/ENG/Monographs/vol38/volume38.pdf (http://monographs.iarc.fr/ENG/Monographs/vol38/volume38.pdf)
   Google Scholar
• IBGE. 1999. National research by household sample. Methodology notes. http://www.ibge.gov.br/home/estatistica/populacao/trabalhoerendimento/pnad99/metodologia (http://www.ibge.gov.br/home/estatistica/populacao/trabalhoerendimento/pnad99/metodologia)
   Google Scholar
• Katiyar , S. , Thelma , B. K. , Murthy , N. S. , Hedau , S. , Jain , N. , Gopalkrishna , V. , Husain , S. A. and Das , B. C. 2003 . Polymorphism of the p53 codon 72 Arg/Pro and the risk of HPV type 16/18-associated cervical and oral cancer in India . Mol. Cell. Biochem. , 252 : 117
   PubMedGoogle Scholar
• Kawamata , Y. , Mitsuhashi , A. , Unno , Y. , Kado , S. , Shino , Y. , Uesugi , K. , Eguchi , O. , Ishii , J. , Seki , K. , Sekiya , S. and Shirasawa , H. 2002 . HPV 16-E6-mediated degradation of intrinsic p53 is compensated by upregulation of p53 gene expression in normal cervical keratinocytes . Int. J. Oncol. , 21 : 561 – 567 .
   PubMedGoogle Scholar
• Kim , J. W. , Lee , C. G. , Park , Y. G. , Kim , K. S. , Kim , I. K. , Sohn , Y. W. , Min , H. K. , Lee , J. M. and Namkoong , S. E. 2000 . Combined analysis of germline polymorphisms of p53, GSTM1, GSTT1, CYP1A1, and CYP2E1: Relation to the incidence rate of cervical carcinoma . Cancer , 88 : 2082 – 2091 .
   PubMedGoogle Scholar
• Kurman , R. J. and Solomon , D. 1994 . The Bethesda system for reporting cervical/vaginal cytologic diagnosis , New York : Springer-Verlag .
   Google Scholar
• Lee , J. , Lee , Y. , Yang , S. , Shi , W. , Luh , S. , Chen , C. , Hsieh , C. and Wu , M. 2000 . Genetic polymorphisms of p53 and GSTP1 but not NAT2 are associated with susceptibility to squamous cell carcinoma of the esophagus . Int. J. Cancer , 89 : 458 – 464 .
   PubMed Web of Science ®Google Scholar
• Lee , J. E. , Lee , S. J. , Namkoong , S. E. , Um , S. J. , Jee , S. H. , You , Y. K. and Park , J. S. 2004 . Gene–gene and gene–environment interactions of p53, p21 and IRF1 polymorphisms in Korean women with cervix cancer . Int. J. Gynecol. Cancer , 14 : 118 – 125 .
   PubMedGoogle Scholar
• Lindstrom , A. , Backström , T. , Hellberg , D. , Tribukait , B. , Strang , P. and Stendahl , U. 2000 . Correlations between serum progesterone and smoking, and the growth fraction of cervical squamous cell carcinoma . Anticancer Res. , 20 : 3637 – 3640 .
   PubMedGoogle Scholar
• Madeleine , M. M. , Shera , K. , Schwartz , S. M. , Daling , J. R. , Galloway , D. A. , Wipf , G. C. , Carter , J. J. , McKnight , B. and McDougall , J. K. 2000 . The p53 Arg72Pro polymorphism, human papillomavirus, and invasive squamous cell cervical cancer . Cancer Epidemiol. Biomarkers Prev. , 9 : 225 – 227 .
   PubMedGoogle Scholar
• Melikian , A. A. , Wang , X. , Waggoner , S. , Hoffmann , D. and El-Bayoumy , K. 1999a . Comparative response of normal and of human papillomavirus-16 immortalized human epithelial cervical cells to benzo[a]pyrene . Oncol. Rep. , 6 : 1371 – 1376 .
   PubMed Web of Science ®Google Scholar
• Melikian , A. A. , Sun , P. , Prokopczyk , B. , El-Bayoumy , K. , Hoffmann , D. , Wang , X. and Waggoner , S. 1999b . Identification of benzo[a]pyrene metabolites in cervical mucus and DNA adducts in cervical tissues in humans by gas chromatography–mass spectrometry . Cancer Lett. , 146 : 127 – 134 .
   PubMed Web of Science ®Google Scholar
• Miller , A. S. , Dykes , D. D. and Polesky , H. F. 1988 . A simple procedure for extracting DNA from human nucleated cells . Nucleic Acid Res. , 16 : 215
   Web of Science ®Google Scholar
• Nishikawa , A. , Fujimoto , T. , Akutagawa , N. , Iwasaki , M. , Takeuchi , M. , Fujinaga , K. and Kudo , R. 2000 . p53 Polymorphism (codon-72) has no correlation with the development and the clinical features of cervical cancer . Int. J. Gynecol. Cancer , 10 : 402 – 407 .
   PubMedGoogle Scholar
• Parkin, D. M., Whelan, S. L., Ferlay, J., and Storm H. 2005. Cancer incidence in five continents, vols. I–VIII. IARC CancerBase No. 7. Lyon: IARC. http://www-dep.iarc.fr/ (http://www-dep.iarc.fr/) (Accessed: 21 July 2009 ).
   Google Scholar
• Parra , F. C. , Amado , R. C. , Lambertucci , J. R. , Rocha , J. , Antunes , C. M. and Pena , S. D. 2008 . Color and genomic ancestry in Brazilians . Proc. Natl. Acad. Sci. USA , 100 : 177 – 182 .
   Google Scholar
• Rothman , K. J. and Greenland , S. 1998 . Modern epidemiology , 2nd , Edited by: Khoury , M. J. Philadelphia : Lippicott-Raven . Genetic Epidemiologyed
   Google Scholar
• Santos , A. M. , Sousa , H. , Catarino , R. , Pinto , D. , Pereira , D. , Pinto , D. , Catarino , R. , Rodrigues , C. , Araújo , A. P. , Lopes , C. and Medeiros , R. 2005 . TP53 codon 72 polymorphism and risk for cervical cancer in Portugal . Cancer Genet. Cytogenet. , 159 : 143 – 147 .
   PubMedGoogle Scholar
• Sasson , I. M. , Haley , N. J. , Hoffmann , D. , Wynder , E. L. , Hellberg , D. and Nilsson , S. 1985 . Cigarette smoking and neoplasia of the uterine cervix: Smoke constituents in cervical mucus . N. Engl. J. Med. , 312 : 315 – 316 .
   PubMed Web of Science ®Google Scholar
• Schiffman , M. and Kjaer , S. K. 2003 . Chapter 2: Natural history of anogenital human papillomavirus infection and neoplasia . J. Natl. Cancer Inst. Monogr. , 200331 : 14 – 19 .
   Google Scholar
• Sedman , S. A. , Barbosa , M. S. , Vass , W. C. , Hubbert , N. L. , Haas , J. A. , Lowy , D. R. and Schiller , J. T. 1991 . The full-length E6 protein of human papillomavirus type 16 has transforming and trans-activating activities and cooperates with E7 to immortalize keratinocytes in culture . J. Virol. , 65 : 4860 – 4866 .
   PubMedGoogle Scholar
• Settheetham-Ishida , W. , Kanjanavirojkul , N. , Kularbkaew , C. and Ishida , T. 2005 . Human papillomavirus genotypes and the p53 codon 72 polymorphism in cervical cancer of Northeastern Thailand . Microbiol. Immunol. , 49 : 417 – 421 .
   PubMedGoogle Scholar
• Sherman , L. , Alloul , N. , Golan , I. , Durst , M. and Baram , A. 1992 . Expression and splicing patterns of human papillomavirus type-16 mRNAs in pre-cancerous lesions and carcinomas of the cervix, in human keratinocytes immortalized by HPV 16, and in cell lines established from cervical cancers . Int. J. Cancer , 50 : 356 – 364 .
   PubMed Web of Science ®Google Scholar
• Simons , A. M. , Phillips , D. H. and Coleman , D. V. 1994 . DNA adduct assay in cervical epithelium . Diagnostic Cytopathol. , 10 : 284 – 288 .
   PubMedGoogle Scholar
• Soulitzis , N. , Sourvinos , G. , Dokianakis , D. N. and Spandidos , D. A. 2002 . p53 codon 72 polymorphism and its association with bladder cancer . Cancer Lett. , 179 : 1751 – 1783 .
   Google Scholar
• Sousa , H. , Santos , A. M. , Pinto , D. and Medeiros , R. 2007 . Is the p53 codon 72 polymorphism a key biomarker for cervical cancer development? A meta-analysis review within European population . Int. J. Mol. Med. , 20 : 731 – 741 .
   PubMedGoogle Scholar
• Storey , A. , Thomas , M. , Kalita , A. , Harwood , C. , Gardiol , D. , Mantovani , F. , Breuer , J. , Leigh , I. M. , Matlashewski , G. and Banks , L. 1998 . Role of a p53 polymorphism in the development of human papillomavirus-associated cancer . Nature , 393 : 229 – 234 .
   PubMed Web of Science ®Google Scholar
• Vieira , J. O. , da Silva , I. D. , Higo , P. E. , Nogueira-de-Souza , N. C. and Gebrin , L. H. 2008 . Study of p53 codon 72 polymorphism in patients with breast cancer . Eur. J. Gynaecol. Oncol. , 29 : 364 – 367 .
   PubMedGoogle Scholar
• Villa , L. L. 1996 . Papilomavirus Humano e Câncer de colo de Útero , 60 – 67 . São Paulo : L. Haes . pp.
   Google Scholar
• Waggoner , S. E. and Wang , X. 1994 . Effect of nicotine on proliferation of normal, malignant, and human papillomavirus-transformed human cervical cells . Gynecol. Oncol. , 55 : 91 – 95 .
   PubMed Web of Science ®Google Scholar
• Wiencke , J. K. 2002 . DNA adduct burden and tobacco carcinogenesis . Oncogene , 21 : 7376 – 7391 .
   PubMed Web of Science ®Google Scholar
• Zehbe , I. , Voglino , G. , Wilander , E. , Genta , F. and Tommasino , M. 1999 . Codon 72 polymorphism of p53 and its association with cervical cancer . Lancet , 354 : 218 – 219 .
   PubMed Web of Science ®Google Scholar
• zur Hausen , H. 2000 . Papillomaviruses causing cancer: Evasion from host-cell control in early events in carcinogenesis . JNCI , 92 : 690 – 698 .
   PubMed Web of Science ®Google Scholar